Literature DB >> 18805604

Cardiovascular risk and memory in non-demented elderly women.

Sophia Wang1, Diane Jacobs, Howard Andrews, Wei-Yann Tsai, Xiaodong Luo, Christine Bergmann, Mary Sano.   

Abstract

OBJECTIVE: To determine whether cardiovascular (CV) risk is associated with subtle memory deficits in non-demented, healthy older women with a family history of Alzheimer disease (AD).
METHODS: Baseline data of 375 participants from a randomized, double-blind placebo-controlled primary prevention trial to test the efficacy of hormone replacement therapy in delaying AD and cognitive decline were analyzed. All subjects were women over 65 with a family history of AD who had normal cognition and no active heart disease at baseline. A baseline memory composite score was calculated, consisting of immediate and delayed recall of verbal and nonverbal material. Multiple linear regression was performed to examine the association of relative CV risk with memory functioning; age, ethnicity and education level were included as covariates.
RESULTS: Mean baseline memory composite score was significantly higher in those with low relative CHD risk than those with high relative CHD risk.
CONCLUSION: These findings suggest that subtle elevation of CHD risk may negatively affect memory functioning even in otherwise healthy, non-demented older women without a history of heart disease. Copyright 2008 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805604      PMCID: PMC2900768          DOI: 10.1016/j.neurobiolaging.2008.08.007

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Aggregation of vascular risk factors and risk of incident Alzheimer disease.

Authors:  J A Luchsinger; C Reitz; L S Honig; M X Tang; Steven Shea; R Mayeux
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

2.  Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.

Authors:  Ann Marie McNeill; Ronit Katz; Cynthia J Girman; Wayne D Rosamond; Lynne E Wagenknecht; Joshua I Barzilay; Russell P Tracy; Peter J Savage; Sharon A Jackson
Journal:  J Am Geriatr Soc       Date:  2006-09       Impact factor: 5.562

Review 3.  Cardiovascular disease and risk of Alzheimer's disease.

Authors:  Caterina Rosano; Anne B Newman
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

Review 4.  Cardiac risk factors and potential treatments in Alzheimer's disease.

Authors:  Christine Bergmann; Mary Sano
Journal:  Neurol Res       Date:  2006-09       Impact factor: 2.448

5.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

6.  Stroke risk profile, brain volume, and cognitive function: the Framingham Offspring Study.

Authors:  S Seshadri; P A Wolf; A Beiser; M F Elias; R Au; C S Kase; R B D'Agostino; C DeCarli
Journal:  Neurology       Date:  2004-11-09       Impact factor: 9.910

Review 7.  Multiple risk factors for cardiovascular disease and diabetes mellitus.

Authors:  Sidney C Smith
Journal:  Am J Med       Date:  2007-03       Impact factor: 4.965

8.  Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.

Authors:  Shaista Malik; Nathan D Wong; Stanley S Franklin; Tripthi V Kamath; Gilbert J L'Italien; Jose R Pio; G Rhys Williams
Journal:  Circulation       Date:  2004-08-23       Impact factor: 29.690

9.  Framingham stroke risk profile and lowered cognitive performance.

Authors:  Merrill F Elias; Lisa M Sullivan; Ralph B D'Agostino; Penelope K Elias; Alexa Beiser; Rhoda Au; Sudha Seshadri; Charles DeCarli; Philip A Wolf
Journal:  Stroke       Date:  2004-01-15       Impact factor: 7.914

  9 in total
  5 in total

1.  Effect of leisure activities on inflammation and cognitive function in an aging sample.

Authors:  Feng Lin; Elliot Friedman; Jill Quinn; Ding-Geng Din Chen; Mark Mapstone
Journal:  Arch Gerontol Geriatr       Date:  2012-02-27       Impact factor: 3.250

2.  Evaluating cognition in an elderly cohort via telephone assessment.

Authors:  Effie M Mitsis; Diane Jacobs; Xiaodong Luo; Howard Andrews; Karen Andrews; Mary Sano
Journal:  Int J Geriatr Psychiatry       Date:  2010-05       Impact factor: 3.485

3.  Ten-year change in plasma amyloid beta levels and late-life cognitive decline.

Authors:  Olivia I Okereke; Weiming Xia; Dennis J Selkoe; Francine Grodstein
Journal:  Arch Neurol       Date:  2009-10

4.  Co-morbidity and drug treatment in Alzheimer's disease. A cross sectional study of participants in the dementia study in northern Norway.

Authors:  Fred Andersen; Matti Viitanen; Dag S Halvorsen; Bjørn Straume; Torgeir A Engstad
Journal:  BMC Geriatr       Date:  2011-10-04       Impact factor: 3.921

5.  Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Elizabeth Guerrero-Berroa; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Andrew Levy; Jeremy M Silverman; Michal Schnaider-Beeri
Journal:  Diabetes Care       Date:  2013-08-29       Impact factor: 19.112

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.